Outlook of Global and Chinese Veterinary Diagnostic Industry 2015-2020

Published time:2015-11-25

Document type:PDF

Language version:English/Chinese

Published by AskCI

No. Content Page
Executive summary
Methodology
1 Veterinary diagnostic products
1.1 Diagnostic methods
1.2 Major veterinary diseases
1.3 Technology
1.3.1 Global technology level
1.3.2 Chinese technology level
2 Companion animal diagnostics market
2.1 Market size, growth and segmentation
2.1.1 Global market
2.1.2 Chinese market
2.2 Market factors
2.3 End user markets
2.4 Regulation
2.4.1 Regulations in China
2.4.2 Regulations in other countries
3 Food animal diagnostics market
3.1 Market size, growth and segmentation
3.1.1 Global market
3.1.2 Chinese market
3.2 Market factors
3.3 End user markets
3.4 Regulation
3.4.1 Regulations in China
3.4.2 Regulations in other countries
4 Chinese animal diagnostics industry operation
4.1 Chinese veterinary drug industry operation
4.1.1 Chinese veterinary drug manufacturing industry operation by regions
4.1.2 Chinese veterinary biological products industry operation
4.1.3 Chinese animal diagnostics industry operation
4.2 Import/export scale by major cities
5 Industry and competition
5.1 Competitive market shares
5.2 New entrants
5.3 Buyer power
5.4 Supplier power
5.5 Threat of substitution
5.6 Rivals
5.7 Chinese industry status
5.7.1 Revenue
5.7.2 Cost
5.7.3 Profitability
6 Major Players
6.1 Global players
6.1.1 IDEXX
6.1.2 Abaxis
6.1.3 Heska
6.2 Chinese major service providers
6.2.1 Mindray Medical International Limited
6.2.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
6.2.3 DaAn Gene Co., Ltd. of Sun Yat-sen University
7 Forecast
7.1 Global market growth trend
7.2 Chinese market growth trend
7.3 Drivers and barriers
8 Conclusion and recommendation
The veterinary diagnostics market is popular in the U.S. and Europe. Companion animal diagnostics makes up large proportion of the market in the globe compared with food animal diagnostics. The rest of the world see great potentials in the market and would continue to grow in the future. In terms of the Chinese market, food animal diagnostics has better performance than companion animal diagnostics. As some diseases are required to be tested by the authority, government tender sales make up part of the food animal diagnostics market share.

The global veterinary diagnostics market was $1,750 million in 2014, with $1026 million in companion animal diagnostics market and $724 million in food animal diagnostics. The companion animal diagnostics market continued to grow in the past few years and the largest market is the U.S. By contrast, food animal diagnostics is more popular in Europe, with market size fluctuated in the past few years. New eradication programs, ongoing surveillance or new pathogenic threats are among the factors for market growth.

Food animal diagnostics in China saw a bigger market size compared with companion animal market, and was around ¥103 million. In addition, there were 475 veterinary drug producers in China, with about 60% of them located in eastern China and central China. Veterinary diagnostics market has intense competition as the entry level is low. Meanwhile, IDEXX is the giant in the market as it makes up 39% of total market share, while the second key player Abaxis makes up 8%. In major player analysis, both global and Chinese players are discussed in terms of revenue and market distribution.

In this report, information about the veterinary diagnostics market, companion animal market, food animal diagnostics and key players in the globe and in China will be discussed. Forecast of the market and recommendations will be given at the end of the report.
Figure No. Figure Title
Figure 1 Technical principles of ELISA
Figure 2 Diagrams of lateral flow tests
Figure 3 Global market size of companion animal diagnostics, 2010-2014
Figure 4 Market share of companion animal diagnostics by major segments, 2014
Figure 5 Market share of companion animal diagnostics by regions, 2014
Figure 6 Chinese market size of companion animal diagnostics, 2010-2014
Figure 7 Chinese market share of companion animal diagnostics by animals, 2014
Figure 8 North American pet insurance market revenues, 2008 and 2013
Figure 9 Age of dogs and cats by % of US household in 2014
Figure 10 Market share of companion animal diagnostics by end users, 2014
Figure 11 Global food animal diagnostics market ($ millions), 2010-2014
Figure 12 Global food animal diagnostics market segmentation in 2014
Figure 13 Food animal diagnostics market share by country/region
Figure 14 Chinese food animal diagnostics market (¥1,000), 2010-2014
Figure 15 Chinese food animal diagnostics market value by disease
Figure 16 Sale revenue of veterinary biological products by animal in China, 2012
Figure 17 Veterinary diagnostics market by competitive share in 2013
Figure 18 IDEXX revenues, 2011-2014
Figure 19 IDEXX revenues by product group/segment in 2014
Figure 20 Abaxis revenues, 2011-2015
Figure 21 Abaxis revenues by segment
Figure 22 Abaxis revenues by product category
Figure 23 Abaxis revenues by geographic region
Figure 24 Heska revenues, 2011-2014
Figure 25 Heska revenues by segment
Figure 26 Revenue and gross profit of Mindray, 2010-2014
Figure 27 Revenue of Mindray by segment, 2014
Figure 28 Revenue of Mindray by region, 2014
Figure 29 Revenue and operating profit of Fosun Pharma, 2010-2014
Figure 30 Revenue and operating profit of DaAn Gene, 2010-2014
Figure 31 Revenue of DaAn Gene’s main business by segment, 2014
Figure 32 Revenue of DaAn Gene’s main business by region, 2014
Figure 33 Global veterinary diagnostics market ($ millions), 2015-2020
Figure 34 Chinese veterinary diagnostics market (¥ thousand), 2015-2020
Table No. Table Title
Table 1 New registered of veterinary diagnostic products in China, 2010-2015
Table 2 Level of pet owner agreement with the statement ‘I’m spending less on pet products because of the economy’, 2010-2014
Table 3 $70+ Household share of US pet market expenditures, 2005-2012
Table 4 Key animal diseases monitoring programs
Table 5 Veterinary drug manufacturing industry operation in China, 2014
Table 6 Company scale of veterinary biological producer in China, 2012
Table 7 Import data of other diagnostic or laboratory reagents and reagent formulation; verification reference
Table 8 Export data of other diagnostic or laboratory reagents and reagent formulation; verification reference
Table 9 Import data of antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
Table 10 Export data of antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
Table 11 Import data of vaccines for veterinary medicine
Table 12 Export data of vaccines for veterinary medicine
Table 13 IDEXX revenues by product group/segment, 2011-2014
Table 14 IDEXX revenue in the U.S. and International Market, 2013-2014
Table 15 Heska revenues by product segment, 2011-2014
Table 16 Heska revenues by region, 2011-2014
Table 17 Revenue of Mindray by segment, 2012-2014
Table 18 Revenue of Mindray by region, 2012-2014
Table 19 Revenue of Fosun Pharma’s main business by segment, 2010-2011
Table 20 Revenue of Fosun Pharma’s main business by segment, 2012-2014
Table 21 Revenue of DaAn Gene’s main business by segment, 2010-2014
Table 22 Revenue of DaAn Gene’s main business by region, 2010-2014